Investigating alexithymia in autism: A systematic review and meta-analysis.


Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
01 2019
Historique:
received: 26 06 2018
revised: 06 08 2018
accepted: 18 09 2018
pubmed: 7 11 2018
medline: 23 3 2019
entrez: 7 11 2018
Statut: ppublish

Résumé

New research suggests that, rather than representing a core feature of autism spectrum disorder (ASD), emotional processing difficulties reflect co-occurring alexithymia. Autistic individuals with alexithymia could therefore represent a specific subgroup of autism who may benefit from tailored interventions. The aim of this systematic review and meta-analysis was to explore the nature and prevalence of alexithymia in autism using the Toronto Alexithymia Scale (TAS). Online scientific databases were searched systematically for studies on ASD popu lations using the TAS. Meta-analyses were performed to evaluate differences in scores between the ASD and neurotypical groups, and to determine the prevalence of alexithymia in these populations. 15 articles comparing autistic and neurotypical (NT) groups were identified. Autistic people scored significantly higher on all scores compared to the NT group. There was also a higher prevalence of alexithymia in the ASD group (49.93% compared to 4.89%), with a significantly increased risk of alexithymia in autistic participants. This review highlights that alexithymia is common, rather than universal, in ASD, supporting a growing body of evidence that co-occurring autism and alexithymia represents a specific subgroup in the ASD population that may have specific clinical needs. More research is needed to understand the nature and implications of co-occurring ASD and alexithymia.

Sections du résumé

BACKGROUND
New research suggests that, rather than representing a core feature of autism spectrum disorder (ASD), emotional processing difficulties reflect co-occurring alexithymia. Autistic individuals with alexithymia could therefore represent a specific subgroup of autism who may benefit from tailored interventions. The aim of this systematic review and meta-analysis was to explore the nature and prevalence of alexithymia in autism using the Toronto Alexithymia Scale (TAS).
METHODS
Online scientific databases were searched systematically for studies on ASD popu lations using the TAS. Meta-analyses were performed to evaluate differences in scores between the ASD and neurotypical groups, and to determine the prevalence of alexithymia in these populations.
RESULTS
15 articles comparing autistic and neurotypical (NT) groups were identified. Autistic people scored significantly higher on all scores compared to the NT group. There was also a higher prevalence of alexithymia in the ASD group (49.93% compared to 4.89%), with a significantly increased risk of alexithymia in autistic participants.
CONCLUSIONS
This review highlights that alexithymia is common, rather than universal, in ASD, supporting a growing body of evidence that co-occurring autism and alexithymia represents a specific subgroup in the ASD population that may have specific clinical needs. More research is needed to understand the nature and implications of co-occurring ASD and alexithymia.

Identifiants

pubmed: 30399531
pii: S0924-9338(18)30177-9
doi: 10.1016/j.eurpsy.2018.09.004
pmc: PMC6331035
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-89

Subventions

Organisme : Medical Research Council
ID : MR/R004595/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S020381/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013700/1
Pays : United Kingdom

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Références

Psychol Psychother. 2006 Mar;79(Pt 1):83-8
pubmed: 16611423
J Autism Dev Disord. 2013 Jul;43(7):1517-26
pubmed: 23114566
Brain. 2010 May;133(Pt 5):1515-25
pubmed: 20371509
J Psychosom Res. 2017 Aug;99:66-81
pubmed: 28712432
Front Integr Neurosci. 2012 Dec 04;6:113
pubmed: 23316143
Assessment. 2006 Mar;13(1):27-45
pubmed: 16443717
J Autism Dev Disord. 2013 Feb;43(2):432-44
pubmed: 22752845
Autism Res. 2009 Jun;2(3):148-56
pubmed: 19575384
Health Psychol Rev. 2013 May;7(Suppl 1):S32-S70
pubmed: 23772230
Psychiatry Res. 2015 May 30;227(1):1-9
pubmed: 25769520
Psychol Med. 2012 Nov;42(11):2453-9
pubmed: 22475181
J Pers Assess. 2007 Dec;89(3):230-46
pubmed: 18001224
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
J Psychosom Res. 2006 Nov;61(5):629-35
pubmed: 17084140
Psychiatry Res. 2013 Aug 15;208(3):257-64
pubmed: 23747233
Psychopathology. 2012;45(1):22-8
pubmed: 22123513
Autism. 2018 Feb;22(2):227-231
pubmed: 27811193
Psychother Psychosom. 1973;22(2):255-62
pubmed: 4770536
J Autism Dev Disord. 2006 May;36(4):573-6
pubmed: 16755385
Hum Brain Mapp. 2018 Mar;39(3):1270-1282
pubmed: 29265723
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
Neuropsychobiology. 2004;49(2):64-70
pubmed: 14981336
J Psychosom Res. 1994 Jan;38(1):23-32
pubmed: 8126686
Neuropsychol Rev. 2010 Sep;20(3):290-322
pubmed: 20809200
Psychol Sci. 2013 May;24(5):723-32
pubmed: 23528789
Psychosomatics. 2000 Sep-Oct;41(5):385-92
pubmed: 11015624
J Psychosom Res. 2003 Dec;55(6):561-8
pubmed: 14642988
Psychother Psychosom. 2000 May-Jun;69(3):117-22
pubmed: 10773774
J Psychosom Res. 2002 Dec;53(6):1083-90
pubmed: 12479990
J Autism Dev Disord. 2009 Jul;39(7):1031-8
pubmed: 19296212
J Autism Dev Disord. 2016 Apr;46(4):1354-67
pubmed: 26659552
J Autism Dev Disord. 2004 Dec;34(6):625-35
pubmed: 15679183
J Autism Dev Disord. 2017 Apr;47(4):961-979
pubmed: 28083780
Front Behav Neurosci. 2015 Mar 06;9:38
pubmed: 25798096
Emotion. 2012 Aug;12(4):659-65
pubmed: 22642342
Biol Psychiatry. 2010 Apr 1;67(7):692-4
pubmed: 19897177
Neuroimage. 2006 Sep;32(3):1472-82
pubmed: 16798016
Neurosci Biobehav Rev. 2015 Sep;56:348-53
pubmed: 26192103
Front Psychol. 2016 Jul 22;7:1103
pubmed: 27501009
Soc Neurosci. 2008;3(2):97-112
pubmed: 18633852
Transl Psychiatry. 2013 Jul 23;3:e285
pubmed: 23880881
J Autism Dev Disord. 2007 Mar;37(3):455-65
pubmed: 16868846
Front Hum Neurosci. 2015 Jan 06;8:991
pubmed: 25610383
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Clin Psychol Rev. 2009 Apr;29(3):216-29
pubmed: 19223098
Eur Psychiatry. 2005 May;20(3):291-8
pubmed: 15935431
Neurosci Biobehav Rev. 2013 Sep;37(8):1774-85
pubmed: 23886515
J Autism Dev Disord. 2004 Apr;34(2):229-35
pubmed: 15162941

Auteurs

Emma Kinnaird (E)

King's College London, London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, UK.

Catherine Stewart (C)

King's College London, London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, UK; South London and Maudsley NHS Foundation Trust, London, UK.

Kate Tchanturia (K)

King's College London, London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, UK; South London and Maudsley NHS Foundation Trust, London, UK; Illia State University, Tbilisi, Georgia. Electronic address: kate.tchanturia@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH